A metabolite extracted from Escherichia coli suppresses tau aggregation. [PDF]
Srinivasan M +8 more
europepmc +1 more source
ABSTRACT The agitation power input substantially impacts the oxygen transfer rate in aerobic fermentation processes. Furthermore, in a carbon‐limited process where the substrate feed rate is controlled by the concentration of dissolved oxygen, the power input will consequently govern the feed rate.
Mariana Albino +6 more
wiley +1 more source
Beyond Inhibition: Rebalancing the Hsp90 Chaperone Network as a Therapeutic Strategy for Alzheimer's Disease. [PDF]
Tang Z +8 more
europepmc +1 more source
Metrics of left ventricular active relaxation reflect proteomic myocardial remodelling and reverse remodelling. [PDF]
Barta BA +12 more
europepmc +1 more source
The modifier matrix: emerging roles of ubiquitin-like proteins in Alzheimer's disease. [PDF]
Yan T, Vaquer J, Springer W, Fiesel FC.
europepmc +1 more source
Multi-omic phenotyping of MAPT V337M neurons reveals early changes in axonogenesis and tau phosphorylation. [PDF]
Mohl GA +13 more
europepmc +1 more source
From Food Additives to Neurodegeneration: The Emerging Role of Polyphosphates in Tauopathies. [PDF]
Barolo L +8 more
europepmc +1 more source
Related searches:
Functions and malfunctions of the tau proteins
Cellular and Molecular Life Sciences, 2002The tau proteins belong to the family of microtubule-associated proteins. They are mainly expressed in neurons where they play major regulatory roles in the organization and integrity of the cytoskeleton network. Neurofibrillary changes of abnormally hyperphosphorylated tau are a key lesion in Alzheimer's disease and a number of other tauopathies ...
Roland Brandt
exaly +3 more sources
Differential distribution of tau proteins in developing cat cerebellum
The differential distribution and phosphorylation of tau proteins in cat cerebellum was studied with two well characterized antibodies, TAU-1 and TAU-2.
Beat M Riederer, Lester I Binder
exaly +2 more sources
Tau protein and tau aggregation inhibitors
Neuropharmacology, 2010Alzheimer disease is characterized by pathological aggregation of two proteins, tau and Abeta-amyloid, both of which are considered to be toxic to neurons. In this review we summarize recent advances on small molecule inhibitors of protein aggregation with emphasis on tau, with activities mediated by the direct interference of self-assembly.
Bulic, B. +3 more
openaire +3 more sources

